Fabrizio Minervini

28PUBLICATIONS
54CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Oct 27, 2026
What Does Standard 5.8 Measure? Nodal Adequacy as an Accountability Metric in Lung Cancer Surgery.

|Oct 27, 2026
Liquid Biopsy-Guided Surgical Decision-Making in Oligometastatic Non-Small Cell Lung Cancer: Toward Dynamic Risk Stratification in the Multidisciplinary Era.

|Aug 13, 2026
Pulmonary Metastasectomy After Liver Transplantation: Indications, Timing, and Surgical Decision-Making Across Primary Tumor Histologies.

|Jul 14, 2026
Visualization of the thoracic sympathetic chain in MLS embalmed body donors: a feasibility study and surgical perspective.

|Jun 26, 2026
Robotic-Assisted Thoracic Surgery in the Immunotherapy Era: Navigating Altered Anatomy, Oncologic Precision, and the Future of Integrated Platforms.

|Mar 11, 2026
Current advances in mediastinal staging for non-small cell lung cancer: a narrative review.

Fabrizio Minervini, Hannes Grünig, Peter Kestenholz

Pageof 5

Frequent Collaborators

8 joint publications

Marco Scarci

7 joint publications

Pietro Bertoglio

7 joint publications

Ugo Cioffi

6 joint publications

Dimitrios E Magouliotis